Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 6/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Sunwels Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥2,601.00 |
52 Week High | JP¥3,585.00 |
52 Week Low | JP¥2,014.00 |
Beta | 0 |
11 Month Change | 1.64% |
3 Month Change | -1.85% |
1 Year Change | -26.84% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 178.68% |
Recent News & Updates
Shareholder Returns
9229 | JP Healthcare | JP Market | |
---|---|---|---|
7D | -6.3% | -1.0% | -0.6% |
1Y | -26.8% | -3.0% | 17.8% |
Return vs Industry: 9229 underperformed the JP Healthcare industry which returned -3% over the past year.
Return vs Market: 9229 underperformed the JP Market which returned 17.8% over the past year.
Price Volatility
9229 volatility | |
---|---|
9229 Average Weekly Movement | 8.0% |
Healthcare Industry Average Movement | 3.4% |
Market Average Movement | 3.9% |
10% most volatile stocks in JP Market | 7.4% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 9229 has not had significant price volatility in the past 3 months.
Volatility Over Time: 9229's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 1,747 | Ryotatsu Nawashiro | sunwels.jp |
Sunwels Co.,Ltd. operates nursing care business centered on PD house. It operates homes for the elderly that specializes in Parkinson disease, as well as a Kaatsu training gym; provides day care, in-home care support, care plan, and home remodeling services; and operates medical specific facilities.
Sunwels Co.,Ltd. Fundamentals Summary
9229 fundamental statistics | |
---|---|
Market cap | JP¥78.57b |
Earnings (TTM) | JP¥2.03b |
Revenue (TTM) | JP¥21.36b |
38.7x
P/E Ratio3.7x
P/S RatioIs 9229 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9229 income statement (TTM) | |
---|---|
Revenue | JP¥21.36b |
Cost of Revenue | JP¥14.94b |
Gross Profit | JP¥6.42b |
Other Expenses | JP¥4.39b |
Earnings | JP¥2.03b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 67.27 |
Gross Margin | 30.07% |
Net Profit Margin | 9.51% |
Debt/Equity Ratio | 91.2% |
How did 9229 perform over the long term?
See historical performance and comparison